CN104225311A - 神经衰弱补益心脾药剂及制法 - Google Patents
神经衰弱补益心脾药剂及制法 Download PDFInfo
- Publication number
- CN104225311A CN104225311A CN201410456625.9A CN201410456625A CN104225311A CN 104225311 A CN104225311 A CN 104225311A CN 201410456625 A CN201410456625 A CN 201410456625A CN 104225311 A CN104225311 A CN 104225311A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- rhizoma
- spleen
- folium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 74
- 210000000952 spleen Anatomy 0.000 title claims abstract description 63
- 210000002216 heart Anatomy 0.000 title claims abstract description 50
- 206010003549 asthenia Diseases 0.000 title claims abstract description 42
- 208000007443 Neurasthenia Diseases 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 25
- 229940079593 drug Drugs 0.000 claims abstract description 23
- 210000000582 semen Anatomy 0.000 claims abstract description 23
- 240000006394 Sorghum bicolor Species 0.000 claims abstract description 22
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000000463 material Substances 0.000 claims abstract description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 239000000843 powder Substances 0.000 claims description 23
- 241001622901 Scomberomorus commerson Species 0.000 claims description 22
- 239000000706 filtrate Substances 0.000 claims description 21
- 235000007230 Sorghum bicolor Nutrition 0.000 claims description 20
- 239000000203 mixture Substances 0.000 claims description 17
- 239000006187 pill Substances 0.000 claims description 16
- 238000011085 pressure filtration Methods 0.000 claims description 14
- 238000010992 reflux Methods 0.000 claims description 14
- 235000014347 soups Nutrition 0.000 claims description 14
- 239000003795 chemical substances by application Substances 0.000 claims description 11
- 238000001816 cooling Methods 0.000 claims description 9
- 241000251468 Actinopterygii Species 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 7
- 235000019688 fish Nutrition 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 239000011812 mixed powder Substances 0.000 claims description 6
- 239000002674 ointment Substances 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000005538 encapsulation Methods 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 28
- 239000002994 raw material Substances 0.000 abstract description 4
- 241000675108 Citrus tangerina Species 0.000 abstract description 3
- 240000002853 Nelumbo nucifera Species 0.000 abstract description 3
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract description 3
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract description 3
- 241001289529 Fallopia multiflora Species 0.000 abstract description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 2
- 241001080798 Polygala tenuifolia Species 0.000 abstract description 2
- 240000006079 Schisandra chinensis Species 0.000 abstract description 2
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract description 2
- 244000205574 Acorus calamus Species 0.000 abstract 1
- 235000006480 Acorus calamus Nutrition 0.000 abstract 1
- 241000167550 Centella Species 0.000 abstract 1
- 241000241550 Cyathula Species 0.000 abstract 1
- 241001522129 Pinellia Species 0.000 abstract 1
- 241000269821 Scombridae Species 0.000 abstract 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 abstract 1
- 240000006023 Trichosanthes kirilowii Species 0.000 abstract 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 abstract 1
- 241000157352 Uncaria Species 0.000 abstract 1
- 241000028204 Vincetoxicum atratum Species 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 235000020640 mackerel Nutrition 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 30
- 239000000047 product Substances 0.000 description 24
- 239000002585 base Substances 0.000 description 21
- 239000000796 flavoring agent Substances 0.000 description 21
- 235000019634 flavors Nutrition 0.000 description 21
- 210000004185 liver Anatomy 0.000 description 21
- 210000003734 kidney Anatomy 0.000 description 20
- 206010062717 Increased upper airway secretion Diseases 0.000 description 18
- 208000026435 phlegm Diseases 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 17
- 239000008280 blood Substances 0.000 description 17
- 230000006870 function Effects 0.000 description 17
- 230000007812 deficiency Effects 0.000 description 16
- 235000009508 confectionery Nutrition 0.000 description 14
- 208000002173 dizziness Diseases 0.000 description 13
- 210000004072 lung Anatomy 0.000 description 13
- 206010011224 Cough Diseases 0.000 description 12
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 12
- 206010022437 insomnia Diseases 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 12
- 208000002193 Pain Diseases 0.000 description 11
- 230000007958 sleep Effects 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 8
- 230000003340 mental effect Effects 0.000 description 8
- 210000000481 breast Anatomy 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 7
- 206010010774 Constipation Diseases 0.000 description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- 206010033557 Palpitations Diseases 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 210000000038 chest Anatomy 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 6
- 230000004438 eyesight Effects 0.000 description 6
- 230000000144 pharmacologic effect Effects 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 206010036790 Productive cough Diseases 0.000 description 5
- 206010047700 Vomiting Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- -1 coniferyl aldehyde glucoside Chemical class 0.000 description 5
- 230000008451 emotion Effects 0.000 description 5
- 229930182470 glycoside Natural products 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 235000021251 pulses Nutrition 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- WUYQEGNOQLRQAQ-CQSZACIVSA-N (+)-pronuciferine Chemical compound C([C@H]1N(C)CCC=2C=C(C(=C3C=21)OC)OC)C13C=CC(=O)C=C1 WUYQEGNOQLRQAQ-CQSZACIVSA-N 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 206010019233 Headaches Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 239000003172 expectorant agent Substances 0.000 description 4
- 230000003419 expectorant effect Effects 0.000 description 4
- 150000002338 glycosides Chemical class 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 4
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- 206010063409 Acarodermatitis Diseases 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- YXVXMURDCBMPRH-UHFFFAOYSA-N Lirinidine Natural products C1C2=CC=CC=C2C2=C(O)C(OC)=CC3=C2C1N(C)CC3 YXVXMURDCBMPRH-UHFFFAOYSA-N 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- ORJVQPIHKOARKV-UHFFFAOYSA-N Nuciferine Natural products C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2C1N(C)CC3 ORJVQPIHKOARKV-UHFFFAOYSA-N 0.000 description 3
- 241000447727 Scabies Species 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 239000003513 alkali Substances 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 208000013116 chronic cough Diseases 0.000 description 3
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 3
- 201000006549 dyspepsia Diseases 0.000 description 3
- 206010015037 epilepsy Diseases 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 229930182478 glucoside Natural products 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 230000001788 irregular Effects 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000015654 memory Effects 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 230000006996 mental state Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 208000005687 scabies Diseases 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 206010042772 syncope Diseases 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- WUYQEGNOQLRQAQ-UHFFFAOYSA-N (+)-pronuciferine Natural products C1=2C3=C(OC)C(OC)=CC=2CCN(C)C1CC13C=CC(=O)C=C1 WUYQEGNOQLRQAQ-UHFFFAOYSA-N 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 2
- AGUISGUERLMHFF-PKIAMQTDSA-N (1s,4r,5s,8r)-1,8-dimethyl-4-propan-2-ylspiro[4.5]decane-3,9-dione Chemical compound CC(C)[C@H]1C(=O)C[C@H](C)[C@]11CC(=O)[C@H](C)CC1 AGUISGUERLMHFF-PKIAMQTDSA-N 0.000 description 2
- VGTALXLMFZXQSK-SORNOFNASA-N (2s,3r,4s,6ar,6br,8as,12as,14br)-2,3-dihydroxy-6b-(hydroxymethyl)-4,6a,11,11,14b-pentamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4,8a-dicarboxylic acid Chemical compound C1[C@H](O)[C@H](O)[C@@](C)(C(O)=O)C2CC[C@@]3(C)[C@]4(CO)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CCC3[C@]21C VGTALXLMFZXQSK-SORNOFNASA-N 0.000 description 2
- MJKVTPMWOKAVMS-UHFFFAOYSA-N 3-hydroxy-1-benzopyran-2-one Chemical compound C1=CC=C2OC(=O)C(O)=CC2=C1 MJKVTPMWOKAVMS-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- LAEJTNRXQGCKMM-UHFFFAOYSA-N Acorone Natural products CC(C)C1CC(=O)C(C)C12CCC(C)C(=O)C2 LAEJTNRXQGCKMM-UHFFFAOYSA-N 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 2
- 241000208340 Araliaceae Species 0.000 description 2
- 206010006100 Bradykinesia Diseases 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- MUVGVMUWMAGNSY-YCBKVTMHSA-N Corynoxeine Natural products O=C(OC)/C(=C\OC)/[C@@H]1[C@@H](C=C)CN2[C@H]([C@@]3(C(=O)Nc4c3cccc4)CC2)C1 MUVGVMUWMAGNSY-YCBKVTMHSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- NMLUOJBSAYAYEM-GZRFBZBPSA-N Dihydro-corynantheine Natural products CC[C@H]1CN2CCc3c([nH]c4ccccc34)[C@H]2C[C@@H]1C(=COC)C(=O)OC NMLUOJBSAYAYEM-GZRFBZBPSA-N 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 2
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 2
- 208000006083 Hypokinesia Diseases 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- WRACWYWAPQQRKC-UHFFFAOYSA-N Madasiatic acid Chemical compound C1C(O)C(O)C(C)(C)C2C(O)CC3(C)C4(C)CCC5(C(O)=O)CCC(C)C(C)C5C4=CCC3C21C WRACWYWAPQQRKC-UHFFFAOYSA-N 0.000 description 2
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 2
- ZYEMGPIYFIJGTP-UHFFFAOYSA-N O-methyleugenol Chemical compound COC1=CC=C(CC=C)C=C1OC ZYEMGPIYFIJGTP-UHFFFAOYSA-N 0.000 description 2
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 2
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- VGTALXLMFZXQSK-UHFFFAOYSA-N Presenegenin Natural products C1C(O)C(O)C(C)(C(O)=O)C2CCC3(C)C4(CO)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C VGTALXLMFZXQSK-UHFFFAOYSA-N 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- TYQALBNCJWAILN-GZBFAFLISA-N acolamone Chemical compound C1CCC(=C)[C@@H]2C(=O)[C@H](C(C)C)CC[C@]21C TYQALBNCJWAILN-GZBFAFLISA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 2
- 229940022757 asiaticoside Drugs 0.000 description 2
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 206010013023 diphtheria Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- ZKNVDVVWFWMIOY-IVCZRNNFSA-N eleutheroside A Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5O[C@H](CC)[C@@H](O)[C@H](O)[C@H]5O)C(C)C ZKNVDVVWFWMIOY-IVCZRNNFSA-N 0.000 description 2
- AGUISGUERLMHFF-UHFFFAOYSA-N epiacorone Natural products CC(C)C1C(=O)CC(C)C11CC(=O)C(C)CC1 AGUISGUERLMHFF-UHFFFAOYSA-N 0.000 description 2
- XIRNKXNNONJFQO-UHFFFAOYSA-N ethyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC XIRNKXNNONJFQO-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical group COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000010685 fatty oil Substances 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 2
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- FGKJLKRYENPLQH-UHFFFAOYSA-N isocaproic acid Chemical compound CC(C)CCC(O)=O FGKJLKRYENPLQH-UHFFFAOYSA-N 0.000 description 2
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- MUVGVMUWMAGNSY-KAXDATADSA-N methyl (e)-2-[(3r,6'r,7's,8'as)-6'-ethenyl-2-oxospiro[1h-indole-3,1'-3,5,6,7,8,8a-hexahydro-2h-indolizine]-7'-yl]-3-methoxyprop-2-enoate Chemical compound O=C1NC2=CC=CC=C2[C@]21CCN1[C@H]2C[C@H](\C(=C/OC)C(=O)OC)[C@@H](C=C)C1 MUVGVMUWMAGNSY-KAXDATADSA-N 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 230000036651 mood Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229960002715 nicotine Drugs 0.000 description 2
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- ORJVQPIHKOARKV-OAHLLOKOSA-N nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- SCWKRWCUMCMVPW-UHFFFAOYSA-N phenyl n-methylcarbamate Chemical group CNC(=O)OC1=CC=CC=C1 SCWKRWCUMCMVPW-UHFFFAOYSA-N 0.000 description 2
- RNYZJZKPGHQTJR-UHFFFAOYSA-N protoanemonin Chemical compound C=C1OC(=O)C=C1 RNYZJZKPGHQTJR-UHFFFAOYSA-N 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 229930193195 schizandrin Natural products 0.000 description 2
- 230000036280 sedation Effects 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- QJVXKWHHAMZTBY-GCPOEHJPSA-N syringin Chemical compound COC1=CC(\C=C\CO)=CC(OC)=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 QJVXKWHHAMZTBY-GCPOEHJPSA-N 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- FKKZBCYPCGDQKZ-UHFFFAOYSA-N tenuifolin Natural products CC1(C)CCC2(CCC3(O)C(=CCC4C5(C)CC(O)C(OC6OC(CO)C(O)C(O)C6O)C(C)(C5CCC34C)C(=O)O)C2C1)C(=O)O FKKZBCYPCGDQKZ-UHFFFAOYSA-N 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 description 2
- NDNUANOUGZGEPO-QMMMGPOBSA-N (+)-coniine Chemical compound CCC[C@H]1CCCCN1 NDNUANOUGZGEPO-QMMMGPOBSA-N 0.000 description 1
- TYQALBNCJWAILN-UHFFFAOYSA-N (-)-(2R,4aS,8aR)-4a-methyl-8-methylene-2-(1-methylethyl)-octahydro-2H-naphthalen-1-one Natural products C1CCC(=C)C2C(=O)C(C(C)C)CCC21C TYQALBNCJWAILN-UHFFFAOYSA-N 0.000 description 1
- VZTUKBKUWSHDFM-CYBMUJFWSA-N (-)-annonaine Chemical compound C1C2=CC=CC=C2C2=C(OCO3)C3=CC3=C2[C@@H]1NCC3 VZTUKBKUWSHDFM-CYBMUJFWSA-N 0.000 description 1
- NMLUOJBSAYAYEM-UHFFFAOYSA-N (-)-corynantheidine Natural products C1=CC=C2C(CCN3CC(C(CC33)C(=COC)C(=O)OC)CC)=C3NC2=C1 NMLUOJBSAYAYEM-UHFFFAOYSA-N 0.000 description 1
- FFDULTAFAQRACT-NYYYOYJKSA-N (-)-syringaresinol O,O'-bis(beta-D-glucoside) Chemical compound COC1=CC([C@H]2[C@H]3[C@H]([C@@H](OC3)C=3C=C(OC)C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)=C(OC)C=3)CO2)=CC(OC)=C1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FFDULTAFAQRACT-NYYYOYJKSA-N 0.000 description 1
- JQNVCUBPURTQPQ-UHFFFAOYSA-N (25R)-Inokosterone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(CO)C)CCC33O)C)C3=CC(=O)C21 JQNVCUBPURTQPQ-UHFFFAOYSA-N 0.000 description 1
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 1
- BOKVLBSSPUTWLV-MRXNPFEDSA-N (R)-N-methylcoclaurine Chemical compound C([C@H]1N(C)CCC=2C=C(C(=CC=21)O)OC)C1=CC=C(O)C=C1 BOKVLBSSPUTWLV-MRXNPFEDSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- HXWZQRICWSADMH-SEHXZECUSA-N 20-hydroxyecdysone Natural products CC(C)(C)CC[C@@H](O)[C@@](C)(O)[C@H]1CC[C@@]2(O)C3=CC(=O)[C@@H]4C[C@@H](O)[C@@H](O)C[C@]4(C)[C@H]3CC[C@]12C HXWZQRICWSADMH-SEHXZECUSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- OQEBBZSWEGYTPG-UHFFFAOYSA-N 3-aminobutanoic acid Chemical class CC(N)CC(O)=O OQEBBZSWEGYTPG-UHFFFAOYSA-N 0.000 description 1
- 241001290610 Abildgaardia Species 0.000 description 1
- 244000296912 Ageratum conyzoides Species 0.000 description 1
- 235000004405 Ageratum conyzoides Nutrition 0.000 description 1
- 241000791841 Alectis ciliaris Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- BRYYLWHNGJJMQM-UHFFFAOYSA-N Anonaine Natural products C1OC2=CC3=CCNC4=C3C(=C2O1)C5=CC=CCC5C4 BRYYLWHNGJJMQM-UHFFFAOYSA-N 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- ZBKFZIUKXTWQTP-KRWDZBQOSA-N Armepavine Natural products C([C@@H]1N(C)CCC=2C=C(C(=CC=21)OC)OC)C1=CC=C(O)C=C1 ZBKFZIUKXTWQTP-KRWDZBQOSA-N 0.000 description 1
- ZBKFZIUKXTWQTP-QGZVFWFLSA-N Armepavine Chemical compound C([C@H]1N(C)CCC=2C=C(C(=CC=21)OC)OC)C1=CC=C(O)C=C1 ZBKFZIUKXTWQTP-QGZVFWFLSA-N 0.000 description 1
- 239000004857 Balsam Substances 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 235000016535 Capraria biflora Nutrition 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Chemical group COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 240000003791 Citrus myrtifolia Species 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 241000207892 Convolvulus Species 0.000 description 1
- TZUGIFAYWNNSAO-XPOGPMDLSA-N Corynantheine Chemical compound N1C2=CC=CC=C2C2=C1[C@@H]1C[C@H](\C(=C/OC)C(=O)OC)[C@@H](C=C)CN1CC2 TZUGIFAYWNNSAO-XPOGPMDLSA-N 0.000 description 1
- BLGXFZZNTVWLAY-DKJBZYCGSA-N Corynanthine Chemical compound C1=CC=C2C(CCN3C[C@@H]4CC[C@H](O)[C@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-DKJBZYCGSA-N 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- BOKVLBSSPUTWLV-UHFFFAOYSA-N D-N-Methyl coclaurine Natural products C1=2C=C(O)C(OC)=CC=2CCN(C)C1CC1=CC=C(O)C=C1 BOKVLBSSPUTWLV-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- NMLUOJBSAYAYEM-XPOGPMDLSA-N Dihydrocorynantheine Chemical compound C1=CC=C2C(CCN3C[C@@H]([C@H](C[C@H]33)\C(=C/OC)C(=O)OC)CC)=C3NC2=C1 NMLUOJBSAYAYEM-XPOGPMDLSA-N 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- DCEFCUHVANGEOE-UHFFFAOYSA-N Ecdysterone Natural products CC(CC(C)(C)O)C(O)C(C)(O)C1CCC2(O)C3=CC(=O)C4CC(O)C(O)CC4(C)C3CCC12C DCEFCUHVANGEOE-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Chemical group 0.000 description 1
- 208000002091 Febrile Seizures Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- 241000146384 Glaux Species 0.000 description 1
- 208000018779 Globus Sensation Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 241001278898 Glycyrrhiza inflata Species 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 240000008669 Hedera helix Species 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 206010019705 Hepatic pain Diseases 0.000 description 1
- 241000024149 Herminium monorchis Species 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- TZUGIFAYWNNSAO-NFYKLEGGSA-N Hirsuteine Natural products N1C2=CC=CC=C2C2=C1[C@H]1C[C@H](/C(=C/OC)C(=O)OC)[C@@H](C=C)CN1CC2 TZUGIFAYWNNSAO-NFYKLEGGSA-N 0.000 description 1
- RTMJLHTXLVZSHA-UHFFFAOYSA-N Hirsutine Natural products COC(=O)C12CCCC=C1CN3CCc4cc(O)c(OC)cc4C23 RTMJLHTXLVZSHA-UHFFFAOYSA-N 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010020852 Hypertonia Diseases 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- JQNVCUBPURTQPQ-FTWMDKANSA-N Inokosterone Natural products O=C1[C@H]2[C@@](C)([C@@H]3C([C@@]4(O)[C@@](C)([C@H]([C@@](O)([C@@H](O)CC[C@H](CO)C)C)CC4)CC3)=C1)C[C@H](O)[C@H](O)C2 JQNVCUBPURTQPQ-FTWMDKANSA-N 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- IQSFEAHJUMVILC-UHFFFAOYSA-N Isorhynchophyllic acid Natural products CCC1CN2CCC3(C2CC1C(=COC)C(=O)O)C(=O)Nc4ccccc34 IQSFEAHJUMVILC-UHFFFAOYSA-N 0.000 description 1
- DAXYUDFNWXHGBE-VKCGGMIFSA-N Isorhynchophylline Chemical compound O=C1NC2=CC=CC=C2[C@]11CCN2C[C@H](CC)[C@@H](\C(=C/OC)C(=O)OC)C[C@H]21 DAXYUDFNWXHGBE-VKCGGMIFSA-N 0.000 description 1
- VCNYNWHVJKWJRQ-UHFFFAOYSA-N Isorhynchophylline Natural products CCC1=CN2CCC3(C2CC1C(=COC)C(=O)OC)C(=O)Nc4ccccc34 VCNYNWHVJKWJRQ-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 241000218377 Magnoliaceae Species 0.000 description 1
- 241000607292 Maguireothamnus speciosus Species 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 241000978093 Metaplexis Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010029412 Nightmare Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 241000209477 Nymphaeaceae Species 0.000 description 1
- 208000022873 Ocular disease Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 240000002948 Ophiopogon intermedius Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Chemical group COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 206010037294 Puerperal pyrexia Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- QMQIQBOGXYYATH-IDABPMKMSA-N Ruscogenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)[C@H](O)C[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 QMQIQBOGXYYATH-IDABPMKMSA-N 0.000 description 1
- BSUPFYRQXCQGLJ-UHFFFAOYSA-N Ruscogenin Natural products CC1CCC2(OC1)OC3C(O)C4C5CC=C6CC(O)CC(O)C6(C)C5CCC4(C)C3C2C BSUPFYRQXCQGLJ-UHFFFAOYSA-N 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 241000612118 Samolus valerandi Species 0.000 description 1
- 229930187077 Schizantherin Natural products 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 241001620072 Scomberomorus niphonius Species 0.000 description 1
- 241000238370 Sepia Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000244155 Taenia Species 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 241000975594 Trichosanthes rosthornii Species 0.000 description 1
- 241000214513 Uncaria sinensis Species 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000107739 Vincetoxicum versicolor Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 238000013475 authorization Methods 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- RKFAZBXYICVSKP-UHFFFAOYSA-N beta- asarone Natural products COC1=CC(OC)=C(C=CC)C=C1OC RKFAZBXYICVSKP-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- RKFAZBXYICVSKP-WAYWQWQTSA-N beta-asarone Chemical compound COC1=CC(OC)=C(\C=C/C)C=C1OC RKFAZBXYICVSKP-WAYWQWQTSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- NKDFYOWSKOHCCO-UHFFFAOYSA-N beta-ecdysone Natural products C1C(O)C(O)CC2(C)C(CCC3(C(C(C)(O)C(O)CCC(C)(O)C)CCC33O)C)C3=CC(=O)C21 NKDFYOWSKOHCCO-UHFFFAOYSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- NNWHUJCUHAELCL-UHFFFAOYSA-N cis-Methyl isoeugenol Natural products COC1=CC=C(C=CC)C=C1OC NNWHUJCUHAELCL-UHFFFAOYSA-N 0.000 description 1
- NNWHUJCUHAELCL-PLNGDYQASA-N cis-isomethyleugenol Chemical compound COC1=CC=C(\C=C/C)C=C1OC NNWHUJCUHAELCL-PLNGDYQASA-N 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 229940077451 coniine Drugs 0.000 description 1
- 229930016881 coniine Natural products 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- TZUGIFAYWNNSAO-UHFFFAOYSA-N corynantheine Natural products N1C2=CC=CC=C2C2=C1C1CC(C(=COC)C(=O)OC)C(C=C)CN1CC2 TZUGIFAYWNNSAO-UHFFFAOYSA-N 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- DVSZKTAMJJTWFG-UHFFFAOYSA-N docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCCC=CC=CC=CC=CC=CC=CC(O)=O DVSZKTAMJJTWFG-UHFFFAOYSA-N 0.000 description 1
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 150000002083 enediols Chemical class 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- QMQIQBOGXYYATH-UHFFFAOYSA-N epiruscogenin Natural products CC1C(C2(CCC3C4(C)C(O)CC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 QMQIQBOGXYYATH-UHFFFAOYSA-N 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 229940067592 ethyl palmitate Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 206010016284 febrile convulsion Diseases 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 229960001867 guaiacol Drugs 0.000 description 1
- 239000008941 guipiwan Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- NMLUOJBSAYAYEM-AZQGJTAVSA-N hirsutine Chemical compound C1=CC=C2C(CCN3C[C@@H]([C@H](C[C@@H]33)\C(=C/OC)C(=O)OC)CC)=C3NC2=C1 NMLUOJBSAYAYEM-AZQGJTAVSA-N 0.000 description 1
- IGMNYECMUMZDDF-UHFFFAOYSA-N homogentisic acid Chemical compound OC(=O)CC1=CC(O)=CC=C1O IGMNYECMUMZDDF-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000005554 hypnotics and sedatives Substances 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- JQNVCUBPURTQPQ-XDWLXSIGSA-N inokosterone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(CO)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 JQNVCUBPURTQPQ-XDWLXSIGSA-N 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 239000002428 insect molting hormone Substances 0.000 description 1
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 1
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- ZOLPMMWNCLHKPX-UHFFFAOYSA-N ligustrin Natural products CC1=CCC2C1C3OC(=C)C(=O)C3C(O)CC2=C ZOLPMMWNCLHKPX-UHFFFAOYSA-N 0.000 description 1
- USOSNFWVEWONDB-UHFFFAOYSA-N liriodendrin Natural products COc1cc(cc(OC)c1OC2OC(CO)C(O)C(O)C2O)C3OC(C)(C)C4C(OC(C)(C)C34)c5cc(OC)c(OC6OC(CO)C(O)C(O)C6O)c(OC)c5 USOSNFWVEWONDB-UHFFFAOYSA-N 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- MQYXUWHLBZFQQO-QGTGJCAVSA-N lupeol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C MQYXUWHLBZFQQO-QGTGJCAVSA-N 0.000 description 1
- PKGKOZOYXQMJNG-UHFFFAOYSA-N lupeol Natural products CC(=C)C1CC2C(C)(CCC3C4(C)CCC5C(C)(C)C(O)CCC5(C)C4CCC23C)C1 PKGKOZOYXQMJNG-UHFFFAOYSA-N 0.000 description 1
- PRAUVHZJPXOEIF-AOLYGAPISA-N madecassic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2[C@H](O)C[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C PRAUVHZJPXOEIF-AOLYGAPISA-N 0.000 description 1
- PRAUVHZJPXOEIF-UHFFFAOYSA-N madecassica acid Natural products C1C(O)C(O)C(C)(CO)C2C(O)CC3(C)C4(C)CCC5(C(O)=O)CCC(C)C(C)C5C4=CCC3C21C PRAUVHZJPXOEIF-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000037306 mature skin Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 229940116837 methyleugenol Drugs 0.000 description 1
- PRHTXAOWJQTLBO-UHFFFAOYSA-N methyleugenol Natural products COC1=CC=C(C(C)=C)C=C1OC PRHTXAOWJQTLBO-UHFFFAOYSA-N 0.000 description 1
- 230000002073 mitogenetic effect Effects 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- 208000024335 physical disease Diseases 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000004793 poor memory Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 229930001545 pronuciferine Natural products 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- XXHSUYNZCSBPBG-GZIDCZEMSA-N quercetin 3-beta-gentiotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC[C@@H]2[C@H]([C@H](O)[C@@H](O)[C@H](OC=3C(C4=C(O)C=C(O)C=C4OC=3C=3C=C(O)C(O)=CC=3)=O)O2)O)O1 XXHSUYNZCSBPBG-GZIDCZEMSA-N 0.000 description 1
- XXHSUYNZCSBPBG-UHFFFAOYSA-N quercetin-3-gentotrioside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OCC2C(C(O)C(O)C(OC=3C(C4=C(O)C=C(O)C=C4OC=3C=3C=C(O)C(O)=CC=3)=O)O2)O)O1 XXHSUYNZCSBPBG-UHFFFAOYSA-N 0.000 description 1
- NDNUANOUGZGEPO-UHFFFAOYSA-N rac-coniine Natural products CCCC1CCCCN1 NDNUANOUGZGEPO-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 229940109990 ruscogenin Drugs 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 229930192961 schisandrol Natural products 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 208000012201 sexual and gender identity disease Diseases 0.000 description 1
- 208000015891 sexual disease Diseases 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- QJVXKWHHAMZTBY-KSXIZUIISA-N syringin Natural products COc1cc(C=CCO)cc(OC)c1O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O QJVXKWHHAMZTBY-KSXIZUIISA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- DKZBBWMURDFHNE-UHFFFAOYSA-N trans-coniferylaldehyde Natural products COC1=CC(C=CC=O)=CC=C1O DKZBBWMURDFHNE-UHFFFAOYSA-N 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 150000008498 β-D-glucosides Chemical class 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种神经衰弱补益心脾药剂及制法,由下列原料药制备而成,均为重量份:炒枳壳5-15,甘草3-6,刺五加6-15,香附8-16,瓜蒌12-18,钩藤9-15,白芍10-16,积雪草7-13,茯神9-12,远志6-15,何首乌3-9,菟丝子6-9,菖蒲5-15,五味子6-12,桑叶4-10,人头七6-12,白薇9-16,橘叶6-15,高粱25-45,川牛膝9-18,玄参6-10,荷叶12-20,半夏10-14,陈皮8-12,马鲛鱼6-10,麦冬5-9。本发明的优良效果还表现在:所选材料皆为传统中药材料,具有补益心脾、安神定志的作用;所用中药原料各成分之间具有药效相互交织、相互促进和协调效能,对治疗神经衰弱、补益心脾有显著的效果。
Description
技术领域
本发明涉及中医中药领域,特别是涉及一种神经衰弱补益心脾药剂及其制备方法。
背景技术
神经衰弱是指由于长期处于紧张和压力下,出现精神易兴奋和脑力易疲乏现象,常伴有情绪烦恼、易激惹、睡眠障碍、肌肉紧张性疼痛等;这些症状不能归于脑、躯体疾病及其他精神疾病。症状时轻时重,波动与心理社会因素有关,病程多迁延。
神经衰弱综合征的发病与精神因素有关。对这一理论的认识,中医书籍中早有记载。如《素身》中写道:“喜伤心”,伤肝”,“思伤脾”,“悲伤肺”,“恐伤肾”,“惊伤胆”。这些描述表明中医对神经衰弱发病的精神因素的重视,而且把人的情绪变化分为怒、喜、思、悲、恐、忧、惊,称为“七情”,同时又注重情志活动与脏腑的关系,把这些不同的情绪变化,与肝、心、脾、肺、肾、胆密切联系起来。肝心脾肺肾等脏器的功能变化,可以表现出不同的精神症状。这说明古人已认识到精神因素不仅可以引起神经衰弱,也可造成脏腑的一些变化;反过来,脏腑的变化,同样可引发精神症状。如《灵枢》中写道:“肝气虚则恐,实则怒,心气虚则悲,实则笑不休。”此外,劳逸失度、久病体虚、饮食不节等都能引起阴阳失交、阳不入阴而形成神经衰弱。现代医学认为,神经衰弱是以大脑机能性障碍为特征的疾病。本病多由工作学习繁重,思想压力大,精神过度紧张或大病,产后气血虚弱伤及脏腑功能,导致心脾亏虚,引起大脑功能活动失调所致。一般采用补益心脾的方法,调整改善人体功能,使相应脏腑功能紊乱得到纠正,使大脑皮层的兴奋与抑制达到平衡,从而提高机体免疫系统。
公开号CN 103948888 A(申请号201410148242.5)的中国专利文献公开了一种用于神经衰弱的中药制剂,其由下述重量份的原料制备而得,玉竹30 份、丹参30份、麦冬30份、女贞子28份、蒲公英28份、五味子28份、茯苓25份、防风25 份、白扁豆25份、山茱萸25份、淫羊藿20份、半夏20份、远志20份、桑椹子20份、首乌20份、栀子17份、钩藤17份、石斛15份、竹茹15份、甜瓜子15份、婆婆针10份、生姜10份、白芍5份、川芎5份、郁金5份、决明子3份。公开号CN 102008643 A(申请号201010580406.3)的中国专利文献公开了一种一种治疗神经衰弱的合剂,该合剂由下列重量份的原料药制成:夜交藤13-17份、合欢皮13-17份、石菖蒲1-5份、仙鹤草13-17份、平地木13-17份、玉竹13-17份、童子益母草13-17份、婆婆针13-17份。授权公告号CN 102552671 A(申请号201210008029.5)的中国专利文献公开了一种治疗神经衰弱的药剂,它是由下列成分按照重量配比制成的:木香3-10 份 枸杞2-6份、萝芙木10-20份、麦冬3-10份、夜交藤3-10份、甘草1-10份、茯苓1-3份、夏枯草3-10份、白芍1-20份、陈皮1-10份、远志2-6份、黄芪5-10份、半夏3-10份、合欢花1-5份、柴胡2-6份。
中医治疗神经衰弱,已有几千年的历史,从《黄帝内经》到《本草纲目》,均有相关药物及配方记载。中药治疗神经衰弱,较之西药的最大的优点在于,从病理上进行根治。缺点在于,起效较慢,病人往往因为服用时间太长而中途放弃。中药的研究以及市场化在国内一直是较为落后,一直到目前都没有一个治疗神经衰弱的中药推向市场。西医治疗神经衰弱主要依赖安定等安眠镇静剂对症治疗,但这些药物在安全性和依赖性方面存在缺陷,副作用比较大,容易形成成瘾性、耐药性,故不宜长时间服用。
发明内容
针对现有技术的不足,本发明的目的是提供一种制备简单、便于携带的神经衰弱补益心脾药剂及其制备方法。该药剂疗效确切且无毒副作用。
本发明的技术方案是:
神经衰弱补益心脾药剂,由下列原料药制备而成,均为重量份:炒枳壳5-15,甘草3-6,刺五加6-15,香附8-16,瓜蒌12-18,钩藤9-15,白芍10-16,积雪草7-13,茯神9-12,远志6-15,何首乌3-9,菟丝子6-9,菖蒲5-15,五味子6-12,桑叶4-10,人头七6-12,白薇9-16,橘叶6-15,高粱25-45,川牛膝9-18,玄参6-10,荷叶12-20,半夏10-14,陈皮8-12,马鲛鱼6-10;麦冬5-9。
优选的方案中,炒枳壳8-12,甘草4-5,刺五加8-13,香附10-14,瓜蒌14-16,钩藤11-13,白芍12-14,积雪草8-12,茯神10-11,远志9-12,何首乌5-7,菟丝子7-8,菖蒲8-12,五味子8-10,桑叶6-8,人头七8-10,白薇11-14,橘叶8-13,高粱30-40,川牛膝11-16,玄参7-9,荷叶14-18,半夏11-13,陈皮9-11,马鲛鱼7-9,麦冬6-8。
更加优选的,炒枳壳10,甘草4.5,刺五加10,香附12,瓜蒌15,钩藤12,白芍13,积雪草10,茯神10.5,远志11,何首乌6,菟丝子7.5,菖蒲10,五味子9,桑叶7,人头七9,白薇13,橘叶11,高粱35,川牛膝13,玄参8,荷叶16,半夏12,陈皮10,马鲛鱼8,麦冬7。
本发明还提供了将前述中药组合物制成药学上可接受的汤剂、稠膏剂、散剂和丸剂的制备方法。
所述汤剂的制备方法是:
(1)将马鲛鱼肉绞碎,与炒枳壳、甘草、刺五加、香附、瓜蒌、钩藤、白芍、积雪草、茯神、远志、何首乌、菟丝子、菖蒲、五味子、人头七、白薇、川牛膝、玄参、半夏、陈皮和麦冬一同置于容器中,加3-6倍(优选4-5倍)原料量的清水浸泡2-5小时(优选3-4小时)加热回流3小时,加压过滤,收集滤液;
(2)将荷叶、桑叶和橘叶洗净后,加入到上述滤渣中,再加2-5倍(优选3-4倍)原料量的清水回流1小时,加压过滤,合并滤液;
(3)将高粱粉碎,加清水,中火慢熬0.5-1小时,过滤,得浓汤;
(4)将步骤(1)所得滤液加入到浓汤中,搅拌均匀,120℃下灭菌(2-5小时),冷却封装,自然冷却,得汤剂。
上述神经衰弱补益心脾的汤剂的制备方法,优选的方案是,步骤(4)灭菌3-4小时(优选3.5小时)。
所述稠膏剂的制备方法是:
(1)将马鲛鱼肉绞碎,与炒枳壳、甘草、刺五加、香附、瓜蒌、钩藤、白芍、积雪草、茯神、远志、何首乌、菟丝子、菖蒲、五味子、人头七、白薇、川牛膝、玄参、半夏、陈皮和麦冬一同置于容器中,加3-6倍(优选4-5倍)原料量的清水浸泡2-5小时(优选3-4小时)加热回流3小时,加压过滤,收集滤液;
(2)将荷叶、桑叶和橘叶洗净后,加入到上述滤渣中,再加2-5倍(优选3-4倍)原料量的清水回流1小时,加压过滤,合并滤液;
(3)将高粱加清水大火熬制,过滤,得浓汤;
(4)将步骤(1)所得滤液加入到浓汤中,搅拌均匀,然后加压浓缩成膏状,冷却,无菌封装,即得稠膏剂。
所述散剂的制备方法是:按配方比例称取各种原料药,先洗净,晒干,再研末,过120-180目筛(优选过140-160目筛),得混合药粉;无菌封装,即得散剂。
所述丸剂的制备方法是:
(1)按配方比例称取各种原料药,先洗净,晒干,再研末,过120-180目筛(优选过140-160目筛),得混合药粉;
(2)按100克药粉配70克蜂蜜,先将蜂蜜置于锅内,用文火熬炼,等蜂蜜熬至粘稠状,再掺入药粉,充分拌匀成药膏;
(3)将上述所得药膏按中医传统制丸方法制成药丸,即得丸剂。
本发明还提供了所述的中药组合物在制备神经衰弱症补益心脾药物时的应用。
本发明所用主要中药原料的药理如下:
马鲛鱼:又名、鲅、马鲅鱼,为鲅科马鲛属动物蓝点马鲛的肉。药性:味甘,性温。成分:脂溶性毒素,雪瓜毒素类物质,二十二碳六烯酸,二十五碳五烯酸。根据现代药理研究发现,该药具有提神、防老、强壮身体的功效,用于产后虚弱,神经衰弱,疥疮,疲乏。
人头七:基原:为兰科角盘兰属植物角盘兰的带块根茎。药性:《山西中草药》:“味甘,性温。”功用主治:补肾健脾,活血调经,解毒。主治头昏失眠,须发早白,不欲食,月经不调,毒蛇咬伤。
刺五加:基原:为五加科五加属植物刺五加的根、根茎或茎叶。成分:根含刺五加苷A、B、B1、C、D、E,刺五加苷A即胡萝卜苷,刺五加苷B即丁香苷;根还含芥子醛葡萄糖苷,松柏醛葡萄糖苷等。药性:《陕西中药志》:“辛,温,入肝、肾二经。”功用主治:益气,补肾,安神,活血。主治脾虚乏力,气虚浮肿,失眠多梦,健忘,腰膝酸软,小儿行迟,胸痹疼痛,久咳,风湿痹痛。
积雪草:基原:为双子叶植物伞形科积雪草的干燥全草或带根全草。成分:含多种α-香树脂醇型的三萜成分,其中有积雪草苷、参枯尼苷、异参枯尼苷,羟基积雪草苷,玻热模苷、破热米苷和破热米酸等,以及马达积雪草酸。药性:苦、辛,寒。归肝、脾、肾经。功用主治:清热解毒,利湿消肿。是东方人的长寿药,可益脑提神。研究表明具有滋补、消炎、愈合伤口、利尿通便和镇定作用。对麻风病、溃疡也有疗效,对血液净化及免疫力有激活作用,因其可刺激深层皮肤细胞的更替。它是神经滋补剂,能提高记忆力,减轻精神疲劳;还可降血压,治疗肝病等。
高粱:基原:为禾本科高粱属植物高粱的种仁。成分:本品幼芽、果实含对羟基扁桃腈葡萄糖苷。药性:甘、涩,温。功用主治:健脾止泻,化痰安神。主治脾虚泄泻,霍乱,消化不良,痰湿咳嗽,失眠多梦。
菟丝子:来源:本品为旋花科植物菟丝子的干燥成熟种子。性味:甘,温。归经:归肝、肾、脾经。功能主治:滋补肝肾,固精缩尿,安胎,明目,止泻。用于阳痿遗精,尿有余沥,遗尿尿频,腰膝酸软,目昏耳鸣,肾虚胎漏,胎动不安,脾肾虚泻;外治白癜风。
菖蒲:性味:辛,苦,性温。归经:归心、胃经。化学成份:含α-、β-细辛醚、顺甲基异丁香酚、甲基丁香酚、菖蒲烯二醇、菖蒲螺烯酮、水菖蒲酮、菖蒲螺酮、菖蒲大牯牛儿酮、菖蒲酮、异菖蒲酮等。能开窍化痰,辟秽杀虫。能为辟秽开窍,宣气逐痰,解毒,杀虫。治癫狂,惊痫,痰厥昏迷,风寒湿痹,噤口毒痢,外敷痈疽疥癣。开窍,化痰,健胃。用于癫痫、痰热惊厥、胸腹胀闷、慢性支气管炎。主治:痰涎壅闭、神识不清、慢性气管炎;痢疾、肠炎、腹胀腹痛、食欲不振、风寒湿痹,外用敷疮疥。
五味子:基原:本品为木兰科植物五味子的干燥成熟果实。化学成份:含五味子素、脱氧五味子素、新一味子素、五味子醇、五味子酯等。药理作用:可提高正常人和眼病患者的视力以及扩大视野;对听力也有良好影响,述可提高皮肤感受器的辨别力。性味:酸、甘,温。归经:归肺、心、肾经。功效:收敛固涩,益气生津,补肾宁心。主治:用于久嗽虚喘,梦遗滑精,遗尿尿频,久泻不止,自汗,盗汗,津伤口渴,短气脉虚,内热消渴,心悸失眠。
桑叶:基原:本品为桑科植物桑的干燥叶。化学成份:叶含芸香甙、槲皮素、异槲皮甙、槲皮素-3-三葡糖甙、微量的β-谷甾醇,和菜油甾醇、β-谷甾醇、β-D-葡糖甙、蛇麻脂醇、内消旋肌醇、昆虫变态激素牛膝甾酮和蜕皮甾酮、溶血素、绿原酸。挥发油成分中有乙酸、丙酸、丁酸、异丁酸、戊酸、异戊酸、己酸、异己酸、水杨酸甲酯、愈创木酚、酚、邻苯甲酚、间苯甲酚、丁香油酚等,又含草酸、延胡索酸、酒石酸、柠檬酸、琥珀酸、棕榈酸、棕榈酸乙酯、三十一烷、羟基香豆精、蔗糖、果糖、葡萄糖、天门冬氨基酸和谷氨酸等氨基酸。性味:甘、苦,寒。归经:归肺、肝经。功效:疏散风热,清肺润燥,清肝明目。主治:用于风热感冒,肺热燥咳,头晕头痛,目赤昏花。
白薇:基原:本品为萝藦摩科植物白薇或蔓生白薇、的干燥根及根茎。化学成份:直立白薇根含白薇素、挥发油、强心甙。性味:苦、咸,寒。归经:归胃、肝、肾经。功效:清热凉血,利尿通淋,解毒疗疮。主治:用于温邪伤营发热,阴虚发热,骨蒸劳热、产后血虚发热,热淋。血淋,痈疽肿毒。
橘叶:来源:为芸香科植物福橘或朱橘等多种橘类的叶。性状:干燥叶多卷缩,平展后呈菱状长椭圆形或椭圆形,表面灰绿色或黄绿色,光滑,对光可照见众多的透明小腺点。性味:苦辛,平。归经:朱震亨:“入足厥阴肝经气分。” 功能主治:疏肝,行气,化痰,消肿毒。治胁痛,乳痈,肺痈,咳嗽,胸膈痞满,疝气。
川牛膝:基原: 本品为苋科植物川牛膝的干燥根。性状:本品呈近圆柱形,微扭曲,向下略细或有少数分枝。表面黄棕色或灰褐色,具纵皱纹、支根痕和多数横向突起的皮孔。性味:甘、微苦,平。归经:归肝、肾经。功效:逐瘀通经,通利关节,利尿通淋。主治:用于经闭癌瘤,胞衣不下,关节痹痛,足康筋挛,尿血血淋,跌扑损伤。
玄参:基原:本品为玄参科植物玄参的干燥根。性状:本品呈类回柱形,中间略粗或上粗下细,有的微弯曲。表面灰黄色或灰褐色,有不规则的纵沟、横长皮孔样突起及稀疏的横裂纹和须根痕。性味:甘、苦、咸,微寒。归经:归肺、胃、肾经。功效:凉血滋阴,泻火解毒。主治:用于热病伤阴,舌绛烦渴,温毒发斑,津伤便秘,骨蒸劳嗽,目赤,咽痛,瘰病,白喉,痈肿疮毒。
荷叶:基原:为睡莲科植物莲的叶。性状:干燥的叶通常折叠成半圆形或扇形,完整或稍破碎。叶片展开后呈圆盾形,直径30余厘米。正面青绿色或棕绿色,有白色短粗腺毛:背面灰黄色或淡灰绿色,平滑有光泽;中心有一突起的叶柄残基;全缘;叶脉明显,由中心向外放射,并分生多数细脉。化学成份:叶含莲碱、荷叶碱、原荷叶碱、亚美罂粟碱、前荷叶碱、N-去甲基荷叶碱、D-N-甲基乌药碱、番荔枝碱、鹅掌楸碱、槲皮素、异槲皮甙、莲甙、酒石酸、柠檬酸、苹果酸、葡萄糖酸、草酸、琥珀酸、鞣质。还含抗有丝分裂作用的碱性成分。性味:苦涩,平。归经:入心、肝、脾经。功能主治:清暑利湿,升发滑阳,止血。治暑湿泄泻、眩晕,水气浮肿,雷头风,吐血,衄血,崩漏,便血,产后血晕。
半夏:来源:为天南星科植物半夏的块茎。化学成份:块茎含挥发油、少量脂肪、淀粉、烟碱、粘液质、天门冬氨酸、谷氨酸、精氨酸、β-氨基丁酸等氨基酸、β-谷甾醇、胆碱、β-谷甾醇-β-D-葡萄糖甙、3,4-二羟基苯甲醛,又含药理作用与毒芹碱及烟碱相似的生物碱、类似原白头翁素刺激皮肤的物质。嫩芽含尿黑酸及其甙。性味:辛,温,有毒。归经:入脾、胃经。功能主治:燥湿化痰,降逆止呕,消痞散结。治湿痰冷饮,呕吐,反胃,咳喘痰多,胸膈胀满,痰厥头痛,头晕不眠。外消痈肿。用于痰多咳喘、痰饮眩悸、内痰眩晕、呕吐反胃、胸脘痞闷、梅核气症;生用外治痈肿痰核。姜半夏多用于降逆止呕。
陈皮:基原:本品为芸香科植物橘及其栽培变种的干燥成熟果皮。性味:苦、辛,温。归经:归肺、脾经。功效:理气健脾,燥湿化痰。主治:用于胸脘胀满.食少吐泻,咳嗽痰多。
白芍:基原: 本品为毛茛科植物芍药的干燥根。化学成份:根含芍药甙、牡丹酚、芍药花甙,苯甲酸约1.07%、挥发油、脂肪油、树脂、鞣质、糖、淀粉、粘液质、蛋白质、β-谷甾醇和三萜类。性味: 苦、酸,微寒。归经: 归肝、脾经。功效: 平肝止痛,养血调经,敛阴止汗。主治: 用于头痛眩晕,胁痛,腹痛,四肢挛痛,血虚萎黄,月经不调,自汗,盗汗。
麦冬:来源:本品为百合科植物麦冬(沿阶草)的干燥块根。性状:本品呈纺锤形,两端略尖。表面黄白色或淡黄色,有细纵纹。质柔韧,断面黄白色,半透明,中柱细小。性味:甘,微苦,微寒。归经:归心、肺、胃经。功能主治:养阴生津,润肺清心。用于肺燥干咳。虚痨咳嗽,津伤口渴,心烦失眠,内热消渴,肠燥便秘;咽白喉。
枳壳:基原:本品为芸香科植物酸橙及其栽培变种的干燥未成熟果实。性味:苦、辛、酸,温。归经:归脾、胃经。功效:理气宽中,行滞消胀。主治:用于胸胁气滞。胀满疼痛,食积不化,痰饮内停;胃下垂,脱肛,子宫脱垂。炒枳壳的制备方法:枳壳除去杂质。洗净,润透,切薄片,干燥后筛去碎落的瓤核。本品为木规则弧状条形薄片。切面外果皮棕褐色至褐色,中果皮黄白色至黄棕色。近外缘有1-2列点状油室,内侧有的有少量紫褐色瓤囊。麸炒枳壳:取枳壳片,照麸炒法炒至色变深。本品为不规则弧状条形薄片,色较深,有的有焦斑。
甘草(生甘草):基原:本品为豆科植物甘草、胀果甘草或光果甘草的干燥根。性味:甘,平。归经:归心、肺、脾、胃经 。功能主治:补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药。用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性。生甘草:将甘草拣去杂质,洗净,用水浸泡至八成透时,捞出,润透切片,晾干。
香附:基原:本品为莎草科植物莎草的干燥根茎。性味:辛、微苦、微甘,平。归经:归肝、脾、三焦经。功效:行气解郁,调经止痛。主治:用于肝郁气滞,胸、胁、脘腹胀痛,消化不良,胸脘痞闷,寒疝腹痛,乳房胀痛,月经不调,经闭痛经。
瓜蒌:基原:本品为葫芦科植物栝楼或双边栝楼的干燥成熟果实。性味:甘、微苦、寒。归经:归肺、胃、大肠经。功能主治:清热涤痰,宽胸散结,润燥滑肠。用于肺热咳嗽,痰浊黄稠,胸痹心痛,结胸痞满,乳痈,肺痈,肠痈肿痛,大便秘结。
钩藤:基原:为茜草科植物钩藤或华钩藤及其同属多种植物的带钩枝条。化学成份:带钩茎枝叶含钩藤碱、异钩藤碱、柯诺辛因碱、异柯诺辛因碱、柯楠因碱、二氢柯楠因碱、硬毛帽柱木碱、硬毛帽柱木因碱。药理作用:①镇静作用,②降压作用。性味:甘,凉。归经:归肝、心经。功能主治“清热平肝,熄风定惊。治小儿惊痫瘈疭,大人血压偏高,头晕、目眩,妇人子痫。
茯神:基原:为多孔菌科植物茯苓菌核中间天然抱有松根(即"茯神木")的白色部分。性味:甘淡,平。归经:入心、脾经。功能主治:宁心,安神,利水。治心虚惊悸,健忘,失眠,惊痫,小便不利。药理作用:镇静作用。
远志:基原:本品为远志科植物远志或卵叶远志的干燥根。化学成份:根含皂甙,水解后可分得两种皂甙元结晶,远志皂甙元A和远志皂甙元B。近又从本植物和同属美远志的根中分离出一种皂甙细叶远志素,即2β,27-二羟基-23-羧基齐墩果酸的3-β-葡萄糖甙。另含远志醇、N-乙酰氨基葡萄糖、生物碱细叶远志定碱、脂肪油、树脂等。性味:苦、辛,温。归经:归心、肾、肺经。功效:安神益智,祛痰,消肿。主治:用于心肾不交引起的失眠多梦、健忘惊悸、神志恍惚,咳痰不爽,疮疡肿毒,乳房肿痛。
何首乌:基原:本品为蓼科植物何首乌的干燥块根。性味:苦、甘、涩.温。归经:归肝、心、肾经。药理作用:①降血脂作用,②降血糖作用,②抗菌作用。功效:解毒,消脱,润肠通便。主治:用于瘰疬疮痈,风疹瘙痒,肠燥便秘;高血脂。
本发明提供的中药组合物组方科学,各种剂型的制备方法简单,所得产品服用方便、便于携带。除此之外,本发明的优良效果还表现在:
1、所选材料皆为传统中药材料,具有补益心脾、安神定志的作用;
2、本发明采用的各中药组分互作配伍,能发挥其协同治病作用,所用中药原料各成分之间具有药效相互交织、相互促进和协调效能,经临床验证,对神经衰弱有很好的治疗效果
3、药材成本低廉,能够减轻患者负担。
具体实施方式
下面结合实施例和实验例详细说明本发明的技术方案,但保护范围不限于此。
实施例1 神经衰弱补益心脾药剂,由下列原料药制备而成:炒枳壳5g,甘草3g,刺五加6g,香附8g,瓜蒌12g,钩藤9g,白芍10g,积雪草7g,茯神9g,远志6g,何首乌3g,菟丝子6g,菖蒲5g,五味子6g,桑叶4g,人头七6g,白薇9g,橘叶6g,高粱25g,川牛膝9g,玄参6g,荷叶12g,半夏10g,陈皮8g,马鲛鱼6g,麦冬5g。
上述神经衰弱补益心脾汤剂的制备方法:
(1)将马鲛鱼肉绞碎,与炒枳壳、甘草、刺五加、香附、瓜蒌、钩藤、白芍、积雪草、茯神、远志、何首乌、菟丝子、菖蒲、五味子、人头七、白薇、川牛膝、玄参、半夏、陈皮和麦冬一同置于容器中,加3-6倍原料量的清水浸泡2-5小时加热回流3小时,加压过滤,收集滤液;
(2)将荷叶、桑叶和橘叶洗净后,加入到上述滤渣中,再加2-5倍原料量的清水回流1小时,加压过滤,合并滤液;
(3)将高粱粉碎,加清水,中火慢熬0.5-1小时,过滤,得浓汤;
(4)将步骤(1)所得滤液加入到浓汤中,搅拌均匀,120℃下灭菌2小时,冷却封装,得汤剂。
本发明汤剂的服用方法:汤剂为10天一个疗程,每天服用两次(温热),每次60m1-100m1。
典型病例:陈xx,男,47岁。5年前,由于工作紧张,不休不眠,连续数日,以致头晕而胀,体力不支,但未曾正规调治,经常睡眠不好,不能多劳,工作繁多时更难入睡。近数月来,失眠严重,每夜最多能睡3小时左右,恶梦纷纭,时时惊醒,精神不振,心情郁闷,焦虑不安,食欲日减,二便如常,舌苔黄,六脉虚数。分析:病人劳倦过度,心脾两虚,营阴暗耗,诊断为神经衰弱。
服用本实施例所得神经衰弱补益心脾汤剂,每天服用两次(温热),每次60m1-100m1,10天一个疗程。服用一个疗程后,患者精神状态好转,睡眠安,纳量增,不适症得到改善;继续服用2个疗程巩固疗效,患者未出现任何不适,患者自感痊愈。
实施例2 神经衰弱补益心脾药剂,由下列原料药制备而成:炒枳壳15g,甘草6g,刺五加15g,香附16g,瓜蒌18g,钩藤15g,白芍16g,积雪草13g,茯神12g,远志15g,何首乌9g,菟丝子9g,菖蒲15g,五味子12g,桑叶10g,人头七12g,白薇16g,橘叶15g,高粱45g,川牛膝18g,玄参10g,荷叶20g,半夏14g,陈皮12g,马鲛鱼10g,麦冬9g。
神经衰弱补益心脾稠膏剂的制备方法是:
(1)将马鲛鱼肉绞碎,与炒枳壳、甘草、刺五加、香附、瓜蒌、钩藤、白芍、积雪草、茯神、远志、何首乌、菟丝子、菖蒲、五味子、人头七、白薇、川牛膝、玄参、半夏、陈皮和麦冬一同置于容器中,加3-6倍(优选4-5倍)原料量的清水浸泡2-5小时(优选3-4小时)加热回流3小时,加压过滤,收集滤液;
(2)将荷叶、桑叶和橘叶洗净后,加入到上述滤渣中,再加2-5倍(优选3-4倍)原料量的清水回流1小时,加压过滤,合并滤液;
(3)将高粱加清水大火熬制,过滤,得浓汤;
(4)将步骤(1)所得滤液加入到浓汤中,搅拌均匀,然后加压浓缩成膏状,冷却,无菌封装,即得稠膏剂。
本发明稠膏剂的服用方法:取一汤匙膏滋,放在杯中,将白开水冲服,每天两次,10天一个疗程。
典型病例:张xx,50岁,公务员,十年前曾感全身疲劳,力不从心,耳鸣眼花,反应迟钝,记忆力减弱,近月来又事多,食少、夜不能寐,脉弦虚,证属气血亏损型神经衰弱,治宣补益气血,健脾补肾。
服用本实施例所得神经衰弱补益心脾稠膏剂两个疗程后各种症状都有缓解,夜寐安稳,食欲正常,精力充沛,能恢复正常工作。继续服用2个疗程,患者痊愈,随访1年,无复发。
实施例3 神经衰弱症补益心脾药剂,由下列原料药制备而成:炒枳壳8g,甘草4g,刺五加8g,香附10g,瓜蒌14g,钩藤11g,白芍12g,积雪草8g,茯神10g,远志9g,何首乌5g,菟丝子7g,菖蒲8g,五味子8g,桑叶6g,人头七8g,白薇11g,橘叶8g,高粱30g,川牛膝11g,玄参7g,荷叶14g,半夏11g,陈皮9g,马鲛鱼7g,麦冬6g。
神经衰弱补益心脾散剂的制备方法是:按配方比例称取各种原料药,先洗净,晒干,再研末,过120-180目筛(优选过140-160目筛),得混合药粉;无菌封装,即得散剂。
本发明散剂的服用方法:将散剂分0.7g/袋。采用每天3次,每次一袋,用温开水冲服,10天一个疗程。
典型病例:黄某,男,37岁,由于工作压力较大,造成精神抑郁、焦虑,经常感到头晕、头昏、反应迟钝,易失眠、多梦,记忆差,经医院诊断为神经衰弱,后服用大量西药治疗,病情有一定控制,但一停药病情便会复发,如此反复,一直不能痊愈。经人介绍后服用本发明实施例所得神经衰弱补益心脾散剂,采用每天3次,每次一袋,用温开水冲服,10天一个疗程。服用一个疗程后,患者精神状态明显好转,睡眠逐渐正常,服药两个疗程后病情痊愈,随访至今无复发。
实施例4 神经衰弱补益心脾药剂,由下列原料药制备而成:炒枳壳12g,甘草5g,刺五加13g,香附14g,瓜蒌16g,钩藤13g,白芍14g,积雪草12g,茯神11g,远志12g,何首乌7g,菟丝子8g,菖蒲12g,五味子10g,桑叶8g,人头七10g,白薇14g,橘叶13g,高粱40g,川牛膝16g,玄参9g,荷叶18g,半夏13g,陈皮11g,马鲛鱼9g,麦冬8g。
神经衰弱补益心脾丸剂的制备方法是:
(1)按配方比例称取各种原料药,先洗净,晒干,再研末,过120-180目筛(优选过140-160目筛),得混合药粉;
(2)按100克药粉配70克蜂蜜,先将蜂蜜置于锅内,用文火熬炼,等蜂蜜熬至粘稠状,再掺入药粉,充分拌匀成药膏;
(3)将上述所得药膏按中医传统制丸方法制成药丸,即得丸剂。
本发明丸剂的服用方法: 每次1丸(载药量约0.7g),每天服用三次(温开水送服),10天一个疗程。
典型病例:谢某,女,19 岁,在校学生,由于临近高考,感觉学习难以胜任,上课时注意不集中,记忆减退,心烦意乱,情绪急躁,夜不能寐,常因小事难过,遇高兴事时有所好转,月经量少色淡、淋漓不尽;面色萎黄,神疲乏力,舌淡,脉弱,服用谷维素、安定等药物治疗3 个月,未见明显好转,心情更加沉重,有时出现烦操、情绪低落,失眠也更为严重,诊断为“心脾两虚型神经衰弱”。
服用本实施例所得神经衰弱补益心脾丸剂,每次1丸,每天服用三次(温开水送服),10天一个疗程。服用两个疗程后,患者精神状态好转,情绪稳定,睡眠安,月经正常,心烦除。继续巩固治疗一个疗程,现在一觉能睡到天亮,早上起床后精神很好,且记忆力有明显改善,随访半年无复发。
实施例5 神经衰弱补益心脾药剂,由下列原料药制备而成:炒枳壳10g,甘草4.5g,刺五加10g,香附12g,瓜蒌15g,钩藤12g,白芍13g,积雪草10g,茯神10.5g,远志11g,何首乌6g,菟丝子7.5g,菖蒲10g,五味子9g,桑叶7g,人头七9g,白薇13g,橘叶11g,高粱35g,川牛膝13g,玄参8g,荷叶16g,半夏12g,陈皮10g,马鲛鱼8g,麦冬7g。
神经衰弱补益心脾汤剂的制备方法是:
(1)将马鲛鱼肉绞碎,与炒枳壳、甘草、刺五加、香附、瓜蒌、钩藤、白芍、积雪草、茯神、远志、何首乌、菟丝子、菖蒲、五味子、人头七、白薇、川牛膝、玄参、半夏、陈皮和麦冬一同置于容器中,加4-5倍原料量的清水浸泡3-4小时加热回流3小时,加压过滤,收集滤液;
(2)将荷叶、桑叶和橘叶洗净后,加入到上述滤渣中,再加加3-4倍原料量的清水回流1小时,加压过滤,合并滤液;
(3)将高粱粉碎,加清水,中火慢熬0.5-1小时,过滤,得浓汤;
(4)将步骤(1)所得滤液加入到浓汤中,搅拌均匀,120℃下灭菌3.5小时,冷却封装,得汤剂。
本发明汤剂的服用方法:汤剂为10天一个疗程,每天服用两次(温热),每次60m1-100m1。
试验例1 实施例5所得神经衰弱补益心脾汤剂的临床应用:2010年7月-2013年6月,选择362例门诊或住院患者。其中男性230例,女性132例,年龄最大73岁,年龄最小17岁。随机分为治疗组和对照组。其中治疗组205例,对照组157例。两组在年龄、性别、临床表现等方面经统计学分析无显著性差异(p> 0.05)。
1、病例选择标准:①、符合中医辩证气血不足、脾气虚弱、心神不宁等症状诊断标准。②、符合西医神经衰弱症状诊断标准。③、病程在3个月以上。
2、治疗方法
治疗组服用本实施例5所得产品,服用方法:每次60m1-100m1,每天服用两次(温热),10天一个疗程。对照组服用其它药品(归脾丸、谷维素、人参健脾丸素等常规药品)。共治疗三个疗程。
3、疗效判断标准:
治愈:神经衰弱、心脾两虚等症状全部消失。显效:神经衰弱、心脾两虚等症状明显缓解。有效:神经衰弱、心脾两虚等症状有所缓解。无效:神经衰弱、心脾两虚等症状无明显变化。结果如表1所示。
表1:服用实施例5产品17-73岁神经衰弱患者治疗结果
治疗效果:治愈176例(85.9%),显效19例(9.3%),有效8例(4.0%),无效2例(1%),总有效率99.2%。效果明显优于对照组。
服用期间自感症状及其精神变化如表2所示。
表2:
本发明选择柴胡、茯神、荷叶、甘草、麦冬等进行配伍,使得这些药物组合后产生协同作用,能够达到补益心脾、治疗神经衰弱的目的。方中柴胡,香附,枳壳、白薇、橘叶、川牛膝、高粱疏肝理气,燥湿化痰。甘草、麦冬、半夏、五味子益气生津、养血润燥。荷叶有清暑利湿、升发滑阳之效。菟丝子、桑叶清肝明目;钩藤、茯神可以镇静安神。诸药合用,共奏补益心脾、养心安神、健脾燥湿之功。服用10天,61%以上的失眠多梦改善;服用20天,79%以上的感到精神状态好转;服用30天,96%以上的心悸怔仲消失,头晕健忘缓解,部分患者自感痊愈。实验组中服用30天以上,有效率可达99.2%,而对照组仅为84.7%。
应当指出的是,具体实施方式只是本发明比较有代表性的例子,显然本发明的技术方案不限于上述实施例,还可以有很多变形。本领域的普通技术人员,以本发明所明确公开的或根据文件的书面描述毫无异议的得到的,均应认为是本专利所要保护的范围。
Claims (10)
1.神经衰弱补益心脾药剂,其特征在于,由下列原料药制备而成,均为重量份:炒枳壳5-15,甘草3-6,刺五加6-15,香附8-16,瓜蒌12-18,钩藤9-15,白芍10-16,积雪草7-13,茯神9-12,远志6-15,何首乌3-9,菟丝子6-9,菖蒲5-15,五味子6-12,桑叶4-10,人头七6-12,白薇9-16,橘叶6-15,高粱25-45,川牛膝9-18,玄参6-10,荷叶12-20,半夏10-14,陈皮8-12,马鲛鱼6-10,麦冬5-9。
2.如权利要求1所述的药剂,其特征在于,炒枳壳8-12,甘草4-5,刺五加8-13,香附10-14,瓜蒌14-16,钩藤11-13,白芍12-14,积雪草8-12,茯神10-11,远志9-12,何首乌5-7,菟丝子7-8,菖蒲8-12,五味子8-10,桑叶6-8,人头七8-10,白薇11-14,橘叶8-13,高粱30-40,川牛膝11-16,玄参7-9,荷叶14-18,半夏11-13,陈皮9-11,马鲛鱼7-9,麦冬6-8。
3.如权利要求1所述的药剂,其特征在于,炒枳壳10,甘草4.5,刺五加10,香附12,瓜蒌15,钩藤12,白芍13,积雪草10,茯神10.5,远志11,何首乌6,菟丝子7.5,菖蒲10,五味子9,桑叶7,人头七9,白薇13,橘叶11,高粱35,川牛膝13,玄参8,荷叶16,半夏12,陈皮10,马鲛鱼8,麦冬7。
4.如权利要求1-3任一所述的药剂,其特征在于,将该药剂制成药学上可接受的汤剂、稠膏剂、散剂和丸剂。
5.如权利要求4所述的药剂,其特征在于,所述汤剂的制备方法是:
(1)将马鲛鱼肉绞碎,与炒枳壳、甘草、刺五加、香附、瓜蒌、钩藤、白芍、积雪草、茯神、远志、何首乌、菟丝子、菖蒲、五味子、人头七、白薇、川牛膝、玄参、半夏、陈皮和麦冬一同置于容器中,加3-6倍(优选4-5倍)原料量的清水浸泡2-5小时(优选3-4小时)加热回流3小时,加压过滤,收集滤液;
(2)将荷叶、桑叶和橘叶洗净后,加入到上述滤渣中,再加2-5倍(优选3-4倍)原料量的清水回流1小时,加压过滤,合并滤液;
(3)将高粱粉碎,加清水,中火慢熬0.5-1小时,过滤,得浓汤;
(4)将步骤(1)所得滤液加入到浓汤中,搅拌均匀,120℃下灭菌(2-5小时),冷却封装,得汤剂。
6.如权利要求5所述的药剂,其特征在于,步骤(4)灭菌3-4小时(优选3.5小时)。
7.如权利要求4所述的药剂,其特征在于,所述稠膏剂的制备方法是:
(1)将马鲛鱼肉绞碎,与炒枳壳、甘草、刺五加、香附、瓜蒌、钩藤、白芍、积雪草、茯神、远志、何首乌、菟丝子、菖蒲、五味子、人头七、白薇、川牛膝、玄参、半夏、陈皮和麦冬一同置于容器中,加3-6倍(优选4-5倍)原料量的清水浸泡2-5小时(优选3-4小时)加热回流3小时,加压过滤,收集滤液;
(2)将荷叶、桑叶和橘叶洗净后,加入到上述滤渣中,再加2-5倍(优选3-4倍)原料量的清水回流1小时,加压过滤,合并滤液;
(3)将高粱加清水大火熬制,过滤,得浓汤;
(4)将步骤(1)所得滤液加入到浓汤中,搅拌均匀,然后加压浓缩成膏状,冷却,无菌封装,即得稠膏剂。
8.如权利要求4所述的药剂,其特征在于,所述散剂的制备方法是:按配方比例称取各种原料药,先洗净,晒干,再研末,过120-180目筛(优选过140-160目筛),得混合药粉;无菌封装,即得散剂。
9.如权利要求4所述的药剂,其特征在于,所述丸剂的制备方法是:
(1)按配方比例称取各种原料药,先洗净,晒干,再研末,过120-180目筛(优选过140-160目筛),得混合药粉;
(2)按100克药粉配70克蜂蜜,先将蜂蜜置于锅内,用文火熬炼,等蜂蜜熬至粘稠状,再掺入药粉,充分拌匀成药膏;
(3)将上述所得药膏按中医传统制丸方法制成药丸,即得丸剂。
10.如权利要求1-3任一所述的中药组合物在制备神经衰弱症补益心脾药物时的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410456625.9A CN104225311A (zh) | 2014-09-10 | 2014-09-10 | 神经衰弱补益心脾药剂及制法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410456625.9A CN104225311A (zh) | 2014-09-10 | 2014-09-10 | 神经衰弱补益心脾药剂及制法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104225311A true CN104225311A (zh) | 2014-12-24 |
Family
ID=52214787
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410456625.9A Pending CN104225311A (zh) | 2014-09-10 | 2014-09-10 | 神经衰弱补益心脾药剂及制法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104225311A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108684783A (zh) * | 2018-06-26 | 2018-10-23 | 成都中医药大学 | 一种黄精蛋糕及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101642540A (zh) * | 2009-06-14 | 2010-02-10 | 李承平 | 一种镇静安神的中成药 |
CN102091231A (zh) * | 2010-12-06 | 2011-06-15 | 济南金鼎信息技术有限公司 | 一种治疗神经衰弱的中药组合物 |
CN102370943A (zh) * | 2011-09-28 | 2012-03-14 | 邓华伦 | 治疗神经衰弱的中草药 |
CN102988742A (zh) * | 2012-12-25 | 2013-03-27 | 马丽 | 一种治疗失眠的中药组合物 |
CN103948888A (zh) * | 2014-04-04 | 2014-07-30 | 谢文茹 | 用于神经衰弱的中药制剂 |
-
2014
- 2014-09-10 CN CN201410456625.9A patent/CN104225311A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101642540A (zh) * | 2009-06-14 | 2010-02-10 | 李承平 | 一种镇静安神的中成药 |
CN102091231A (zh) * | 2010-12-06 | 2011-06-15 | 济南金鼎信息技术有限公司 | 一种治疗神经衰弱的中药组合物 |
CN102370943A (zh) * | 2011-09-28 | 2012-03-14 | 邓华伦 | 治疗神经衰弱的中草药 |
CN102988742A (zh) * | 2012-12-25 | 2013-03-27 | 马丽 | 一种治疗失眠的中药组合物 |
CN103948888A (zh) * | 2014-04-04 | 2014-07-30 | 谢文茹 | 用于神经衰弱的中药制剂 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108684783A (zh) * | 2018-06-26 | 2018-10-23 | 成都中医药大学 | 一种黄精蛋糕及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103341064B (zh) | 一种治疗癃闭的中药组合物 | |
CN103041208B (zh) | 一种治疗妇女更年期综合征的中药制剂及其制备方法 | |
CN104352776A (zh) | 一种治疗月经过少致不孕的中药制剂及其制备方法 | |
CN103719494A (zh) | 一种牛蒡子通便润肠保健茶及其制备方法 | |
CN101607051B (zh) | 一种中药减肥组合物及其制备方法 | |
CN104940740A (zh) | 一种治疗多囊卵巢综合征的中药组合物及其制备方法 | |
CN105664099A (zh) | 一种温补肾阳的中药组合物及其制备方法 | |
CN104958646A (zh) | 一种润肠通便的中药制剂及其制备方法 | |
CN104042891A (zh) | 缓解产妇大便秘结的中药组合物及其制备方法 | |
CN101518594B (zh) | 一种抗肿瘤及增强免疫力的中药制剂及其制备方法 | |
CN104873877A (zh) | 一种降低血糖、调理体质的中药组合物 | |
CN106540167A (zh) | 一种减肥中药 | |
CN105796845A (zh) | 药物组合物在制备治疗女性更年期综合征药物中的用途 | |
CN105381424A (zh) | 一种用于人体脏腑排毒的中药剂及制备方法 | |
CN104353051A (zh) | 一种治疗胃痛的中药制剂及其制备方法 | |
CN104815232A (zh) | 一种治疗原发性肺动脉高压的中药制剂及其制备方法 | |
CN104042981A (zh) | 一种治疗产后便秘的药剂及制备方法 | |
CN104524479B (zh) | 一种治疗经前期综合征的中药组合物及其制备方法 | |
CN103877483A (zh) | 一种治疗慢性胃炎的中药及其制备方法 | |
CN104225311A (zh) | 神经衰弱补益心脾药剂及制法 | |
CN104306583A (zh) | 一种治疗月经量少的中药组合物及其制备方法 | |
CN102861292A (zh) | 一种治疗食管癌的药物及其制备方法 | |
CN104888091A (zh) | 一种治疗肠型急性放射病的中药组合物及其制备方法 | |
CN105125693A (zh) | 一种治疗急性胃炎的中药组合物及其制备方法 | |
CN104606562A (zh) | 一种治疗胸腔积液的行水通络制剂及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 336000, Jiangxi, Yuanzhou District, Xiu Xiu Jiang Road, No. 9, District, No. 2 building 3-501 Applicant after: Zhang Guangmin Address before: After ten road 250014 kilns in Shandong province Ji'nan City Lixia District head quarters Applicant before: Zhang Guangmin |
|
COR | Change of bibliographic data | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20141224 |